LifeMD is trading at $2.35, up 5.38%, as healthcare strength may help explain the gain, though no direct cause is established.

  • Healthcare was up 2.32% during the regular session.
  • No company-specific announcement explaining the October 29 move surfaced; LifeMD’s next quarterly results are scheduled for November 9.
  • Live trading volume was not available in the reliable sources reviewed.